No pain, no gain: Will migraine therapies increase bone loss and impair fracture healing?
- PMID: 32971471
- PMCID: PMC7516061
- DOI: 10.1016/j.ebiom.2020.103025
No pain, no gain: Will migraine therapies increase bone loss and impair fracture healing?
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Predicting erenumab adverse events with single-cell genomics.Lancet. 2020 Jul 11;396(10244):95-96. doi: 10.1016/S0140-6736(19)32952-6. Lancet. 2020. PMID: 32653068 No abstract available.
-
New Drugs for Preventing Migraines.Am J Nurs. 2019 May;119(5):22. doi: 10.1097/01.NAJ.0000557909.12528.af. Am J Nurs. 2019. PMID: 31033548 No abstract available.
-
Targeting calcitonin gene-related peptide: a new era in migraine therapy.Lancet. 2019 Nov 9;394(10210):1765-1774. doi: 10.1016/S0140-6736(19)32504-8. Epub 2019 Oct 23. Lancet. 2019. PMID: 31668411 Review.
-
[CGRP: from neuropeptide to the therapeutic target (background and pathophysiology)].Fortschr Neurol Psychiatr. 2024 Jul;92(7-08):267-276. doi: 10.1055/a-2331-0783. Epub 2024 Jul 18. Fortschr Neurol Psychiatr. 2024. PMID: 39025056 Review. German.
-
Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.Headache. 2019 Jun;59(6):951-970. doi: 10.1111/head.13510. Epub 2019 Apr 25. Headache. 2019. PMID: 31020659 Review.
Cited by
-
Assessment of Bone Mineral Density Over 1 Year in a Cross-Sectional Cohort of Migraine Patients Receiving Anti-CGRP Monoclonal Antibodies.CNS Drugs. 2024 Oct;38(10):819-825. doi: 10.1007/s40263-024-01104-0. Epub 2024 Aug 22. CNS Drugs. 2024. PMID: 39174745 Free PMC article.
-
Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression.Life Sci Alliance. 2024 Sep 12;7(12):e202302041. doi: 10.26508/lsa.202302041. Print 2024 Dec. Life Sci Alliance. 2024. PMID: 39266299 Free PMC article.
-
Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments.Curr Pain Headache Rep. 2022 Jul;26(7):493-504. doi: 10.1007/s11916-022-01051-9. Epub 2022 May 19. Curr Pain Headache Rep. 2022. PMID: 35587859 Review.
-
Role of the Peripheral Nervous System in Skeletal Development and Regeneration: Controversies and Clinical Implications.Curr Osteoporos Rep. 2023 Oct;21(5):503-518. doi: 10.1007/s11914-023-00815-5. Epub 2023 Aug 14. Curr Osteoporos Rep. 2023. PMID: 37578676 Free PMC article. Review.
-
Elevated Bone Resorption Markers in Patients With Migraine: A Case Series.J Clin Neurol. 2022 Nov;18(6):720-722. doi: 10.3988/jcn.2022.18.6.720. J Clin Neurol. 2022. PMID: 36367071 Free PMC article. No abstract available.
References
-
- Charles A., Pozo-Rosich P. Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet. 2019;394(10210):1765–1774. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical